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Kremen 1 and 2 have been identified as co-receptors
for Dickkopf (Dkk) proteins, hallmark secreted antag-
onists of canonical Wnt signaling. We present here
three crystal structures of the ectodomain of human
Kremen1 (KRM1ECD) at resolutions between 1.9 and
3.2 A˚. KRM1ECD emerges as a rigid molecule with
tight interactions stabilizing a triangular arrangement
of its Kringle, WSC, and CUB structural domains. The
structures reveal an unpredicted homology of the
WSCdomain to hepatocyte growth factor.We further
report the general architecture of the ternary
complex formed by the Wnt co-receptor Lrp5/6,
Dkk, and Krm, determined from a low-resolution
complex crystal structure between b-propeller/EGF
repeats (PE) 3 and 4 of the Wnt co-receptor LRP6
(LRP6PE3PE4), the cysteine-rich domain 2 (CRD2) of
DKK1, and KRM1ECD. DKK1CRD2 is sandwiched
between LRP6PE3 and KRM1Kringle-WSC. Modeling
studies supported by surface plasmon resonance
suggest a direct interaction site between Krm1CUB
and Lrp6PE2.
INTRODUCTION
Signaling by Wnt morphogens is renowned for its fundamental
roles in embryonic development, tissue homeostasis, and stem
cell maintenance (Holstein, 2012). Due to these functions, gen-
eration, delivery, and interpretation of Wnt signals are all heavily
regulated in the animal body (Clevers and Nusse, 2012; Niehrs,
2012; Malinauskas and Jones, 2014; Kakugawa et al., 2015).
Vertebrate Dickkopf proteins (Dkk1, 2, and 4) are one of
many secreted antagonists of Wnt and function by blocking ac-
cess to the Wnt co-receptor LRP5/6 (Semenov et al., 2001;
Mao et al., 2001; Bafico et al., 2001). Kremen proteins (Krm1
and Krm2) have been identified as additional high-affinity trans-
membrane receptors for Dkk (Nakamura et al., 2001, 2008;
Mao et al., 2002). Krm and Dkk synergize in Wnt inhibition dur-
ing Xenopus embryogenesis to regulate anterior-posterior
patterning (Davidson et al., 2002). Mechanistically it is thoughtStructure 24, 1599–1605, Septe
This is an open access article undthat, in the presence of Dkk, Krm forms a ternary complex with
Lrp6, which is then rapidly endocytosed. This amplifies the
intrinsic Wnt antagonistic activity of Dkk by efficiently depleting
the cell surface of the Wnt co-receptor (Mao et al., 2002). In
accordance with this, Krm1/ and Krm2/ double knockout
mice show a high bone mass phenotype typical of increased
Wnt signaling, as well as growth of ectopic forelimb digits.
Growth of ectopic digits is further enhanced upon additional
loss of dkk expression (Ellwanger et al., 2008; Schulze et al.,
2010). The Wnt antagonistic activity of Krm1 is also linked to
its importance for correct thymus epithelium formation in
mice (Osada et al., 2006). The importance of intact KRM1 for
normal human development and health is highlighted by the
recent finding that a homozygous mutation in the ectodomain
of KRM1 leads to severe ectodermal dysplasia including oligo-
dontia (Issa et al., 2016). Interestingly, the Wnt antagonistic
activity of Krm is context dependent, and Krm proteins are
actually dual-mode Wnt regulators. In the absence of Dkk,
Krm1 and 2 change their function from inhibition to enhance-
ment of Lrp6-mediated signaling. By direct binding to Lrp6
via the ectodomains, Krm proteins promote Lrp6 cell-surface
localization and hence increase receptor availability (Hassler
et al., 2007; Cselenyi and Lee, 2008). Further increasing the
complexity of Krm functionality, it was recently found that
Krm1 (but not Krm2) can also act independently of LRP5/6
and Wnt as a dependence receptor, triggering apoptosis unless
bound to Dkk (Causeret et al., 2015).
Structurally, Krm1 and 2 are type I transmembrane proteins
with a 40 kDa ectodomain and a flexible cytoplasmic tail consist-
ing of 60–75 residues. The ectodomain consists of three similarly
sized structural domains of around 10 kDa each: the N-terminal
Kringle domain (KR) is followed by a WSC domain of unknown
fold (Verna et al., 1997). The third structural domain is a CUB
domain (Romero et al., 1997). An approximately 70-residue linker
connects the CUB domain to the transmembrane span. An intact
KR-WSC-CUB domain triplet and membrane attachment is
required for Wnt antagonism (Mao et al., 2002). The transmem-
brane span and cytoplasmic tail can be replacedwith aGPI linker
without impact on Wnt antagonism (Mao et al., 2002; Causeret
et al., 2015).
We sought to provide structural insights into the multi-
functionality of this cell-surface receptor. The structures
presented here reveal the unknown fold of the WSC domain
and the tight interactions of all three domains. We furthermber 6, 2016 ª 2016 The Authors. Published by Elsevier Ltd. 1599
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1. Diffraction and Refinement Statistics
KRM1ECD KRM1ECD KRM1ECD KRM1ECD LRP6PE3PE4-DKKCRD2-KRM1ECD
Crystal form I I II III I
X-ray source Diamond i04 Diamond i03 Diamond i03 Diamond i04 Diamond i04
Wavelength (A˚) 0.9793 0.9700 0.9700 0.9795 0.9795
Space group P3121 P3121 P43 P41212 C2221
Unit cell a/a (A˚/) 50.9/90 50.5/90 65.8/90 67.8/90 86.9/90
b/b (A˚/) 50.9/90 50.5/90 65.8/90 67.8/90 100.1/90
c/g (A˚/) 188.4/120 187.4/120 75.0/90 198.2/90 270.7/90
Wilson B factor (A˚2) 31 41 76 77 NA
Resolution range (A˚) 47.10–1.90
(1.95–1.90)
62.47–2.10
(2.16–2.10)
75.00–2.80
(2.99–2.80)
67.80–3.20
(3.42–3.20)
67.68–3.50
(7.16–6.40, 3.92–3.50)
Unique reflections 23,300 (1,524) 17,089 (1,428) 7,964 (1,448) 8,171 (1,343) 8,070 (723, 645)
Average multiplicity 9.1 (9.2) 5.2 (5.3) 3.7 (3.7) 22.7 (12.6) 3.8 (3.5, 4.4)
Completeness (%) 99.8 (98.5) 100 (100) 99.8 (100) 98.8 (93.4) 51.6 (98.5, 14.1)
<I/sI> 11.4 (1.7) 12.0 (1.7) 14.9 (1.5) 13.1 (1.9) 4.6 (4.1, 2.2)
Rmerge (%) 14.8 (158.3) 9.3 (98.0) 6.2 (98.9) 29.8 (142.2) 44.9 (40.5, 114.2)
Rpim (%) 15.7 (55.3) 10.3 (109.0) 3.7 (53.8) 6.3 (40.0) 24.7 (23.9, 59.9)
Refinement
Rwork (%) 17.9 18.4 21.6 20.2 32.1
Rfree (%) 22.7 23.2 30.7 27.1 35.5
No. of Non-Hydrogen Atoms
Protein 2,260 2,301 2,102 2,305 7,730
N-glycans 42 42 28 28 0
Water 79 54 0 2 0
Ligands 6 6 2 5 0
Average B factor (A˚2)
Protein 63 65 108 84 –
N-glycans 35 46 102 18 –
Water 68 85 – 75 –
Ligands 36 47 91 75 66
RMSD from Ideality
Bond lengths (A˚) 0.020 0.016 0.019 0.016 0.004
Bond angles () 2.050 1.748 1.952 1.796 0.770
Ramachandran Plot
Favored (%) 96.8 95.5 96.9 94.9 92.3
Allowed (%) 99.7 100.0 100.0 99.7 99.8
Number of outliers 1 0 0 1 2
PDB code 5FWS 5FWT 5FWU 5FWV 5FWW
Values in parentheses refer to the highest-resolution shell. An additional shell given for the ternary complex corresponds to the last shell with near-
complete diffraction data. NA, not announced.succeeded in determination of a low-resolution LRP6PE3PE4-
DKK1CRD2-KRM1ECD complex, defining the architecture of
the Wnt inhibitory complex that leads to Lrp6 cell-surface
depletion.
RESULTS
The recombinant production of the extracellular domain of Krm
for structural studies proved challenging (see Experimental Pro-
cedures). We succeeded in purifying KRM1ECD complexes with
DKK1fl, DKK1Linker-CRD2, and DKK1CRD2 that were monodisperse1600 Structure 24, 1599–1605, September 6, 2016and stable in gel filtration, hence indicating at least micromolar
affinity (data not shown). Several crystal forms were obtained
from these complexes, however, crystals always contained
only KRM1 protein.
We solved the structure of KRM1ECD in three crystal forms at
1.9, 2.8, and 3.2 A˚ resolution (Table 1). The high-resolution
structure is a near full-length model (Figure 1). The small, flex-
ible, and charged 98AEHED102 loop could only be modeled in a
slightly lower resolution structure and in crystal form III. The KR,
WSC, and CUB are arranged in a roughly triangular fashion with
tight interactions between all three domains. The KR domain,
Figure 1. Structure of Unliganded KRM1ECD
(A) The KRM1ECD fold (crystal form I) colored blue
to red from the N to C terminus. Cysteines as ball
and sticks, glycosylation sites as sticks. The bound
calcium is shown as a gray sphere. The site of
the F207S mutation associated with ectodermal
dysplasia in humans is shown as mesh.
(B) Superposition of the three KRM1ECD sub-
domains (solid) with their next structurally char-
acterized homologs (half transparent).
(C) Superposition of KRM1ECD from the three
crystal forms. Alignment scores for each pairing
are indicated on the dashed triangle.which bears two of the four glycosylation sites, contains the
canonical three disulfide bridges (C32-C114, C55-C95, C84-
C109) and, like other Kringle domains, is low in secondary
structure elements. The structurally most similar Kringle domain
is that of human plasminogen (PDB: 1PKR; Wu et al., 1994) with
an root-mean-square deviation (RMSD) of 1.7 A˚ for 73 aligned
Ca (Figure 1B). The KRM1 structure reveals the fold of the WSC
domain for the first time. The structure is best described as a
sandwich of a b1-b5-b3-b4-b2 antiparallel b sheet and a single
a helix. The structure is also rich in loops and is stabilized by
four disulfide bridges (C122-C186, C147-C167, C151-C169,
C190-C198). Using the PDBeFold server, we detected a sur-
prising yet significant homology to PAN module domains (Tor-
dai et al., 1999). The closest structural relative is hepatocyte
growth factor (HGF, PDB: 1GP9; Watanabe et al., 2002), which
superposes with an RMSD of 2.3 A˚ for 58 aligned Ca
(Figure 1B). The CUB domain bears two glycosylation sites.
Although present, the quality of the electron density around
N217 did not allow modeling of the sugar moiety. In crystal
form I, a calcium ion is present at the canonical position (Ga-
boriaud et al., 2011) coordinated by the carboxylates of
D263, D266 (bidentate), and D306, as well as the carbonyl of
N309 and a water molecule. The coordination sphere deviates
significantly from perfectly octahedral (not shown). This might
result in the site having a low affinity and may explain why
calcium is not present in the two low-resolution crystal forms.
Loss of calcium has led to loop rearrangements and partial
disorder in these crystal forms. The closest structural relative
is the CUB_C domain of Tsg-6 (PDB: 2WNO; Briggs et al.,
2015), which superposes with KRMCUB with an RMSD of
1.6 A˚ for 104 Ca (Figure 1B).
A superposition of the three KRM1 structures reveals no major
structural differences (Figure 1C) as anticipated from the
plethora of interactions between the three domains. Minor differ-Structurences are caused by the collapse of the
Ca2+ binding site in crystal forms II and
III and loop flexibility in the KR domain.
The F207S mutation recently found to
cause ectodermal dysplasia in Palestinian
families (Issa et al., 2016) maps to the
hydrophobic core of the protein at the
interface of the three subdomains (Fig-
ure 1A). Such a mutation is bound to
severely destabilize the protein structureof KRM1, leading to disturbance of its Wnt antagonistic, Wnt
stimulatory, and Wnt independent activity.
Low-Resolution Insight into Ternary Complex Formation
Co-crystallization of LRP6PE3PE4 with DKK1CRD2, and LRP6PE1
with an N-terminal peptide of DKK1 has provided valuable struc-
tural insight into direct Wnt inhibition by Dkk ligands (Cheng
et al., 2011; Ahn et al., 2011; Bourhis et al., 2011; Bao et al.,
2012). One face of the rather flat DKK1CRD2 fragment binds to
the third b propeller of LRP6. Mutational analyses further implied
that the LRP6PE3-averted face of DKK1CRD2 bears the Krm bind-
ing site, hence suggesting how Dkk can recruit both receptors
into a ternary complex (Wang et al., 2008).
To obtain direct insight into ternary complex formation by
Lrp5/6, Dkk, and Krm, we subjected an LRP6PE3PE4-DKK1fl-
KRM1ECD complex to crystallization trials. Diffraction data
collected from the resulting crystals were highly anisotropic
with diffraction extending in the best directions to 3.5 A˚ and
3.7 A˚ but only to 6.4 A˚ in the third direction. Despite the lack of
high-resolution diffraction, the general architecture of the ternary
complex is revealed (Figure 2A). DKK1CRD2 binds to the top face
of the LRP6 PE3 b propeller as described earlier for the binary
complex (Cheng et al., 2011; Ahn et al., 2011). KRM1ECD does
indeed bind on the opposite side of DKK1CRD2 with only its KR
and WSC domains engaged in binding (Figure 2A). Although
present in the complex subjected to crystallization, we observe
no density that could correspond to CRD1 or the domain
linker (L). We confirm that the CRD2 of DKK1 is required and
sufficient for binding to KRM1 (Mao and Niehrs, 2003): In surface
plasmon resonance (SPR), we measured low micromolar affinity
between full-lengthDKK1 and immobilizedKRM1ECD (Figure 2B).
A SUMO fusion of DKK1L-CRD2 displayed a similar (slightly higher)
affinity. In contrast, a SUMO fusion of DKK1CRD1-L did not display
binding for concentrations tested up to 325 mM (Figure 2B).e 24, 1599–1605, September 6, 2016 1601
Figure 2. Insight into Ternary Complex
Formation
(A) The structure of the ternary LRP6PE3PE4-
DKK1CRD2-KRM1ECD complex. DKK1 (orange) is
sandwiched between the PE3 module of LRP6
(blue) and the KR-WSC domain pair of KRM1
(green). Colored symbols indicate introduced
N-glycan attachment sites (see D).
(B) SPR data comparing binding of full-length
DKK1 and SUMO fusions of DKK1 truncations for
binding to immobilized wild-type KRM1ECD.
(C) Close-up view of the DKK1CRD2-KRM1ECD
interface. Residues involved in interface formation
are shown as sticks; those mentioned in the text
are labeled. Salt bridges are in pink and hydrogen
bonds in black. Model bias cannot be excluded
as single atoms and bonds are not resolved at
6.4–3.5 A˚. See also Figure S1.
(D) SPR binding data comparing DKK1 analyte
binding with wild-type KRM1ECD and three variants
bearing engineered glycosylation sites on the KR
and WSC domains (green and blue pointing to
DKK1) and on the CUB domain (orange). See also
symbols in (A).Overall, the DKK1-KRM1 interface is characterized by a large
number of polar interactions but only few hydrophobic contacts
(Figure 2C). The crystal structure gives an explanation for DKK1
loss-of-binding mutations identified previously (Wang et al.,
2008): R191 of DKK1 forms a double salt bridge to D125 and
E162 of KRM1 (Figure 2C). A charge reversal as in the mouse
Dkk1 (mDkk1) R197E variant would severely disrupt the binding.
Similarly, the K226 side chain of DKK1, which points to a small
hydrophobic pocket on the surface of KRM1 formed by Y108,
W94, and W106, forms salt bridges with the side chains of
KRM1 D88 and D90. Again, a charge reversal as shown before
for mDkk1 K232E would be incompatible with binding. The
side chain of DKK1 S192 was also predicted to be involved in
Krm binding (Wang et al., 2008). Indeed, we found (Figure 2C)
that the side chain of D201 of KRM1 forms two hydrogen bonds
to the side-chain hydroxyl and the backbone amide of S192
(mouse, S198). Additional polar interactions are formed between
the N140, S163, and Y165 side chains of KRM1 and DKK1 back-
bone carbonyls of W206, L190, and C189, respectively. The
carbonyl of DKK1 R224 is hydrogen bonded to Y105 and
W106 of KRM1. We suspect that the Dkk charge reversal
mutations performed in the murine background and shown
to diminish Krm binding K211E and R203E (mouse K217E
and R209E; Chen et al., 2008) do so likely indirectly by disrup-
tion of the Dkk fold. We further validated the DKK1 binding
site on KRM1 by introducing glycosylation sites at the KR
(90DVS92/NVS) and WSC (189VCF191/NCS) domains pointing
toward DKK (Figures 2A and 2D). Introduction of N-linked gly-
cans in protein-protein-binding sites is an established way of
disrupting protein-binding interfaces. Both ectodomain mutants
were secreted comparably with the wild-type, indicating correct
folding, but failed to achieve any detectable binding in SPR using
full-length DKK1 as analyte. In contrast, a mutant carrying an
additional N-glycan outside the interface at the CUB domain
(309NQA311/NQS), was wild-type-like in DKK1 binding
(Figure 2D).1602 Structure 24, 1599–1605, September 6, 2016Identification of a Direct LRP6-KRM1 Binding Site
The LRP6PE3PE4-DKK1CRD2-KRM1ECD complex structure reveals
no direct interactions between KRM1 and LRP6.We constructed
in silico a ternary complex with a close to full-length LRP6
ectodomain (PE1PE2PE3PE4 horse shoe) similar to Chen et al.
(2011) but without refinement against electron microscopy
(EM) or small-angle X-ray scattering data. An auxiliary PE3PE4
fragment was superimposed via PE4 onto PE3 of the crystal
structure, and the LRP6PE1PE2 structure was superimposed via
PE2 onto PE3 of this auxiliary fragment (Figure 3A).
For this crude approximation of a true ternary complex, we
noted very close proximity between the Ca2+-binding region of
KRM1 and the top face of the PE2 b propeller of LRP6. The sol-
vent-exposed residues R307, I308, and N309 of the central
Ca2+-binding b connection loop of KRM1would be almost ideally
positioned for binding to this face, which is commonly used as a
binding site on b propellers. Peptides containing arginine/lysine,
isoleucine, and asparagine (consensus sequence N-X-I-(G)-R/K;
Bourhis et al., 2011) are also employed by DKK1 and SOST to
bind to LRP6 (albeit to propeller 1; Figure 3B). To support the
hypothesis that KRM1CUB binds to LRP6PE2, we used SPR and
compared binding of the wild-type and the GlycoCUB mutant
of KRM1ECD (bearing an N-glycosylation site at N309) with a pu-
rified LRP6PE1PE2 fragment. Indeed, we found that in the absence
of Dkk, KRM1ECD bound with considerable affinity to LRP6PE1PE2
(Figure 3C). In contrast, no saturable binding was observed
between KRM1 and LRP6PE3PE4. Introduction of an N-glycosyla-
tion site at N309 in KRM1ECD abolished LRP6PE1PE2 binding
(Figure 3C), while binding to DKK1 was unaffected (Figure 2D).
We conclude that the predicted binding site between KRM1CUB
and LRP6PE2 is a strong candidate for mediating the direct
Lrp6-Krm interaction, which is thought to increase Wnt respon-
siveness by stabilizing Lrp6 at the cell surface (Hassler et al.,
2007; Cselenyi and Lee, 2008). Further experiments are required
to pinpoint the exact binding site. Although LRP6PE1 appears
somewhat out of reach in themodeled ternary complex, it cannot
Figure 3. LRP6-KRM1 Direct Interaction
and Summary
(A) In a construction of a ternary complex with all
four b propellers of LRP6 intact, the CUB domain
points via its Ca2+-binding region toward the top
face of the second b propeller.
(B) Close-up view of the potential interaction site.
In addition, LRP6PE2 has been superimposed with
DKK1 (yellow) and SOST (pink) peptide complexes
of LRP6PE1.
(C) SPR measurements comparing LRP6PE1PE2
binding with wild-type KRM1ECD and the GlycoCUB
mutant bearing an N-glycan at N309.
(D) Schematic representation of structural and
biophysical findings and their implications for Wnt-
dependent (left, middle) and independent (right)
signaling. Conformational differences in the de-
pictions of LRP6 are included purely for ease of
representation.be excluded as the Krm binding site in the ternary complex and
LRP6-Krm binary complex. The presence of DKK may govern
which propeller (PE1 versus PE2) of LRP6 is available for Krm
binding.
Apparent binding across the proposed KRM1CUB-LRP6PE2
interface is expected to be higher once Krm is also cross-
linked to LRP6PE3 via DKK1CRD2 (Figure 3D). Low-resolution
negative-stain EM and small-angle X-ray scattering studies
of LRP6PE1PE2PE3PE4, in isolation and in complex with Dkk1
(Cheng et al., 2011; Ahn et al., 2011), plus negative-stain EM
of full-length LRP6 ectodomain (Chen et al., 2011), have indi-
cated curved, platform-like conformations but also potential
flexibility between PE2 and PE3. It is therefore possible that
the interplay of Krm and Dkk binding can promote changes
in LRP6 ectodomain conformation with functional conse-
quences; however, such ideas await investigation.
Taken together, the structural and biophysical studies we
report here extend our mechanistic understanding of Wnt signal
regulation. We describe the ectodomain structure of the dual
Wnt regulator Krm1, providing an explanation for the detrimental
effect on health and development of a homozygous KRM1muta-
tion. We also reveal the interaction mode of Krm-Dkk and the
architecture of the ternary complex formed by Lrp5/6, Dkk,
and Krm. Furthermore, the ternary crystal structure has guided
in silico and biophysical analyses to suggest a direct LRP6-
KRM1 interaction site. Our findings provide a solid foundation
for additional studies to probe how ternary complex formation
triggers internalization, whereas Krm binding in the absence of
Dkk stabilizes the Wnt co-receptor at the cell surface.
EXPERIMENTAL PROCEDURES
Large-Scale Mammalian Expression and Protein Purification
KrmECD fragments were cloned into pHLsec or variants thereof (Seiradake
et al., 2015). Full ectodomain variants (e.g., KRM1 isoform 3, P30-T377)Structurwere well secreted into the conditioned medium
(CM) of HEK293T cells, but exhibited extensive
O-glycosylation (as judged from smeary bands
in western blot), which would be detrimental
to crystallization. Fragments truncated to theKR-WSC-CUB core gave sharp bands but were barely secreted. We therefore
engineered an A23-G373 (isoform 1 numbering used throughout the article)
full ectodomain construct (KRM1ECD-TEV) with a C-terminal His10 tag
that contained a TEV protease cleavage site after E324. The expected
sequence of the secreted protein is ETG-23APSPGLGPGPE31 .
320AVKEE324-GSENLYFQGGS-325LPQ . VPG373-THHHHHHHHHH (the iso-
form-2-specific PG insertion and the TEV site are underlined). This construct
was well secreted and could be processed using TEV protease. However,
80%–90% of the protein eluted as aggregates from a size-exclusion column
even before TEV treatment. The same applied to analog constructs for Krm1
from zebrafish, frog, and mouse. No monomeric protein at all could be
obtained for several Krm2 constructs from multiple species. A KRM1ECD-TEV
expressing stable GntI-deficient HEK293S cell line was generated by excision
of an EcoRI-XhoI fragment, sub-cloning into pNeo-Sec-1, and selection of
neomycin-resistant cells (Seiradake et al., 2015). The stable cell line showed
expression levels superior to transiently transfected cells (not shown).
Human LRP6PE1PE2, LRP6PE3PE4, and full-length DKK1 were produced in a
similar way as described (Chen et al., 2011). Shorter constructs of DKK1 lack-
ing the N-terminal flexible region and CRD1 were not secreted from HEK cells.
However, using the approach of an N-terminal fusion to a modified SUMO
protein as described earlier (Peroutka et al., 2008; Chang et al., 2015), we
succeeded in secretory expression of a SUMO-DKK1Linker-CRD2 construct en-
compassing residues S141-H266. A variant of this containing a TEV cleavage
site just before T181, SUMO-DKK1Linker-TEV-CRD2, was also well expressed and
allowed removal of the flexible linker region.
To obtain complexes of KRM1ECD-TEV, we (co-)transfected the stable cell
line with DKK and LRP6PE3PE4 constructs described earlier (Chen et al.,
2011). Binary and ternary KRM1ECD-DKK1fl and KRM1ECD-DKK1fl-LRP6PE3PE4
complexes were stable in gel-filtration eluting as distinct monodisperse peaks.
Crystallization and Data Collection
All samples subjected to crystallization were purified from CM by affinity and
size-exclusion chromatography (Zebisch et al., 2013; Kakugawa et al.,
2015). After treatment with TEV protease and endoglycosidase F1 overnight
using mass equivalents of 1%, samples were subjected to size-exclusion
chromatography in 10 mM HEPES/NaOH (pH 7.5), 150 mM NaCl. The crystals
giving rise to the 1.9 A˚ dataset for KRM1 in crystal form I were obtained from a
KRM1ECD-DKK1Linker-CRD2 complex concentrated to 12 mg/mL. Out of this
complex, KRM1ECD crystallized alone in 2.0 M ammonium sulfate, 5% (v/v)
iso-propanol. For cryoprotection, crystals were transferred to mother liquore 24, 1599–1605, September 6, 2016 1603
mixed 1:1 with 3.4 M sodium malonate (pH 7.0). The slightly less well-ordered
crystal of crystal form I and crystals of form II were obtained from a KRM1ECD-
DKK1CRD2 complex using the SUMO-DKK1Linker-TEV-CRD2 construct and
releasing SUMO and the DKK linker region by TEV and 3C protease treatment.
Crystals of form I (2.1 A˚) appeared from protein at 12 mg/mL in 1.0 M (NH4)
H2PO4, 0.100 M sodium citrate (pH 5.6) and were cryoprotected by transfer
to 2.9 M sodium malonate (pH 5.0). Crystals of form II grew from protein
concentrated to 17 mg/mL in 1.0 M MgSO4, 0.1 M trisodium citrate (final pH
5.6). For cryoprotection, crystals were transferred to mother liquor mixed 1:3
with 3.0 M ammonium sulfate, 18% glycerol. Crystal form III appeared after
11 months in a dried-out drop of condition H5 of the Morpheus screen. The
protein concentration had been 9 mg/mL. For cryoprotection, fresh liquid
from Morpheus/H5 was added. The ternary complex structure was obtained
from an LRP6PE3PE4-DKK1fl-KRM1ECD complex at 9 mg/mL that grew in
condition E10 of the PACTpremier screen (pH approximately 6.8) over the
course of 2–11 months. For cryoprotection, 10% PEG200 was added. By
mistake, the crystals were incubated for 1 hr with 1 mM platinum compound
in this cryosolution before cryocooling.
Structure Determination
Diffraction data were collected at DIAMOND synchrotron light source at the
beamlines detailed in Table 1. The structure was initially solved from crystal
form III by molecular replacement (MR) with PHASER (McCoy et al., 2007),
placing models for the CUB domain (PDB: 2WNO, CUB_C domain of Tsg-6
(Briggs et al., 2015), 37% sequence identity), and the KR domain (PDB:
1PKR, Kringle 1 of plasminogen; Wu et al., 1994; 39% sequence identity).
Traceable density for the WSC domain became immediately evident. The
KRM1 structure was then built and refined by cycling between the various
crystal forms.
For the ternary complex, we obtained only a low-resolution, highly aniso-
tropic dataset extending to Bragg spacings of 3.5 A˚, 6.4 A˚, and 3.7 A˚ along
the three principle directions (<I/sI> = 2). All data to 3.5 A˚ were used during
structure determination by MR. LRP6PE3PE4 (PDB: 4A0P; Chen et al., 2011)
and KRM1ECD (both stripped of glycosylation sites) could be placed inde-
pendently by PHASER, giving Z scores of >10 and log likelihood gains
(LLG) of >200. The combined LLG was 673, increasing to 901 after rigid-
body refinement. Strong electron density became apparent at glycosyla-
tion sites and close to methionines (see platinum soak above), further
supporting the MR solution. Additional strong density was evident between
LRP6 and KRM1, suggesting the presence of DKK1. A model of the
DKK1CRD2 (PDB: 3S2K and 3S8V (Cheng et al., 2011; Ahn et al., 2011))
could then be placed with PHASER by testing all rotation function peaks.
This increased the LLG from 901 to 973 indicating a correct solution. The
individually placed LRP6 and DKK models were then replaced with chains
B and C from the LRP6-DKK complex in PDB: 3S2K. The structure
was subjected to rigid-body refinement using single structural domains
as individually positioned bodies.
We then performed restrained refinement of the coordinates against the el-
lipsoidally truncated and anisotropically scaled (Strong et al., 2006) diffraction
data as obtained from the diffraction anisotropy server at UCLA. The resolution
cutoffs were 3.5 A˚, 6.4 A˚, and 3.7 A˚. Strong geometric restraints generated by
PROSMART from the available high-resolution reference structures were used
during refinement. No manual model building was attempted. Restrained
refinement was followed by ten cycles of structure idealization. The final model
had Rwork/Rfree errors of 32.5%/36.1% against the anisotropy-corrected data
and 32.1%/35.5% against the unmodified but ellipsoidally truncated (Zebisch
et al., 2012) diffraction data.
Surface Plasmon Resonance
Equilibrium experiments were performed as described before (Zebisch et al.,
2013; Kakugawa et al., 2015) with the addition of 2 mM CaCl2 for experiments
investigating the direct LRP6PE1PE2-KRM1ECD interaction.ACCESSION NUMBERS
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